Comparison of Alternative Androgen Receptor-axis-targeted Agent (ARATA) and Docetaxel as Second-line Therapy for Patients With Metastatic Castration-resistant Prostate Cancer With Progression After Initial ARATA in Real-world Clinical Practice in Japan

Publication | Closed Access

DOI

Citations

References

2017

Year

Hideaki Miyake, Takayuki Sugiyama, Ryota Aki, Yuto Matsushita, Keita Tamura, Daisuke Motoyama, Toshiki Ito, Atsushi Otsuka

Clinical Genitourinary Cancer

UrologyOncologyReal-world Clinical PracticeGenitourinary CancerMedicineInitial ArataPharmacotherapyCancer TreatmentProstatic DiseaseSecond-line TherapyPharmacology